Maze Therapeutics, Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

45.08

-1.89 (-4.02%)

At close: Feb 18, 2026, 4:00 PM EST

45.03

-0.05 (-0.11%)

After-hours: Feb 18, 2026, 4:50 PM EST

Maze Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.06	0.14	4.94	0.32
Debt / EBITDA Ratio	-	0.40	-	-
Debt / FCF Ratio	-	0.36	-	-
Net Debt / Equity Ratio	-0.95	-0.86	2.04	-0.67
Net Debt / EBITDA Ratio	2.73	-2.79	-0.22	0.63
Net Debt / FCF Ratio	3.33	-2.27	-0.23	0.67
Asset Turnover	-	1.07	-	-
Quick Ratio	17.40	9.52	1.79	4.81
Current Ratio	17.70	9.76	2.09	5.11
Return on Equity (ROE)	-52.69%	50.48%	-180.12%	-
Return on Assets (ROA)	-27.37%	23.07%	-55.63%	-
Return on Invested Capital (ROIC)	-634.89%	196.80%	-307.50%	-330.64%
Return on Capital Employed (ROCE)	-33.60%	26.20%	-178.60%	-86.00%
Buyback Yield / Dilution	-1176.31%	-19.33%	-13.82%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q